Exact Sciences
EXAS
#1376
Rank
$12.53 B
Marketcap
$69.06
Share price
3.26%
Change (1 day)
4.18%
Change (1 year)
Exact Sciences Corp. is a molecular diagnostics company with an initial focus on the early detection and prevention of colorectal cancer.

Exact Sciences (EXAS) - Cash on Hand

Cash on Hand as of December 2023 : $0.77 B

According to Exact Sciences's latest financial reports the company has $0.77 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Exact Sciences - Cash on Hand chart (from 2001 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31$0.77 B23.03%
2022-12-31$0.63 B-38.66%
2021-12-31$1.03 B-44%
2020-12-31$1.83 B468.5%
2019-12-31$0.32 B-71.21%
2018-12-31$1.12 B164.69%
2017-12-31$0.42 B36.52%
2016-12-31$0.31 B1.38%
2015-12-31$0.30 B8.53%
2014-12-31$0.28 B112.19%
2013-12-31$0.13 B23.25%
2012-12-31$0.10 B15.81%
2011-12-31$93.36 M-2.15%
2010-12-31$95.41 M292.2%
2009-12-31$24.32 M392.77%
2008-12-31$4.93 M-60.78%
2007-12-31$12.58 M-40.28%
2006-12-31$21.07 M-38.23%
2005-12-31$34.11 M-32.14%
2004-12-31$50.28 M80.82%
2003-12-31$27.8 M-36.58%
2002-12-31$43.84 M-22.86%
2001-12-31$56.84 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
$9.92 B 1,176.69%๐Ÿ‡ซ๐Ÿ‡ท France
$0.21 B-72.17%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
$0.14 B-81.88%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.63 M-99.15%๐Ÿ‡บ๐Ÿ‡ธ USA